LAX.SH
TTK HEALTHCARE LIMITED·PHARMACEUTICALS 70.24SEXUAL WELLNESS 64.33
Price
1,102.5
+1.88%52W Range
Market Cap
₹1,557.87 Cr
Traded: ₹3.77 Cr (0.24%) 0.0x
Free Float: ₹316.87 Cr (1.19% of FF traded)
Volume · 60D trend
33.93 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +5.0% | +12.0% | +6.0% | -- | +8.0% | Stable |
| ROE | +19.0% | +22.0% | +7.0% | -- | -- | Stable |
| Return | +1.0% | +8.0% | -2.0% | -2.0% | -- | Stable |
| Profit | +12.0% | +11.0% | -52.0% | -- | +14.0% | Stable |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 258 | 218 | 209 | 204 | 226 | 190 | 205 | 198 | 208 | 181 | 184 | 186 | 202 | 180 |
| Expenses | 243 | 207 | 202 | 198 | 224 | 178 | 197 | 190 | 201 | 169 | 179 | 176 | 192 | 165 |
| Operating Profit | 15 | 11 | 7 | 5 | 3 | 12 | 8 | 8 | 7 | 12 | 5 | 10 | 10 | 15 |
| OPM % | 6.0% | 5.0% | 3.4% | 2.6% | 1.2% | 6.0% | 3.8% | 4.2% | 3.3% | 7.0% | 2.9% | 5.0% | 5.0% | 8.0% |
| Other Income | 17 | 21 | 10 | 19 | 18 | 13 | 18 | 18 | 37 | 16 | 16 | 16 | 15 | 12 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 29 | 30 | 14 | 21 | 18 | 22 | 23 | 23 | 41 | 24 | 18 | 22 | 21 | 23 |
| Tax % | 26.0% | 26.0% | 25.0% | 4.0% | 26.0% | 26.0% | 26.0% | 26.0% | 23.0% | 25.0% | 27.0% | 26.0% | 24.0% | 27.0% |
| Net Profit | 21 | 22 | 11 | 20 | 13 | 16 | 17 | 17 | 32 | 18 | 13 | 16 | 16 | 17 |
| Exceptional Items | -- | 4 | -8 | 0 | 0 | -6 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | -3 |
| EPS (Rs) | 15.1 | 15.4 | 7.5 | 14.4 | 9.2 | 11.4 | 11.8 | 12.2 | 22.4 | 12.9 | 9.1 | 11.3 | 11.1 | 12.0 |
| Sales Growth (YoY) | 14.2% | 14.7% | 1.9% | 3.0% | 8.7% | 5.0% | 11.4% | 6.5% | 3.0% | 0.6% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 18.4% | 4.3% | 2.5% | -9.7% | 18.9% | -7.3% | 3.5% | -4.8% | 14.9% | -1.6% | -1.1% | -7.9% | 12.2% | -- |
| OP Growth (YoY) | 400.0% | -8.3% | -12.5% | -37.5% | -57.1% | 0.0% | 60.0% | -20.0% | -30.0% | -20.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | 36.4% | 57.1% | 40.0% | 66.7% | -75.0% | 50.0% | 0.0% | 14.3% | -41.7% | 140.0% | -50.0% | 0.0% | -33.3% | -- |
| Profit Growth (YoY) | -- | -6.4% | -5.9% | 18.6% | -20.4% | 12.2% | 29.8% | 7.4% | 4.3% | -10.5% | 7.4% | 102.4% | 261.1% | 383.9% |
| EPS Growth (YoY) | 63.7% | 34.7% | -37.1% | 18.6% | -58.8% | -11.6% | 29.8% | 7.4% | 101.5% | 7.8% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -2.2% | 106.7% | -48.4% | 56.9% | -19.5% | -3.5% | -2.7% | -45.5% | 72.8% | 41.8% | -19.5% | 2.2% | -7.5% | -- |
| OP Margin | 5.8% | 5.0% | 3.4% | 2.5% | 1.3% | 6.3% | 3.9% | 4.0% | 3.4% | 6.6% | 2.7% | 5.4% | 5.0% | 8.3% |
| Net Margin | 8.1% | 10.1% | 5.3% | 9.8% | 5.8% | 8.4% | 8.3% | 8.6% | 15.4% | 9.9% | 7.1% | 8.6% | 7.9% | 9.4% |
| Material Cost % | 44.3% | 48.7% | 46.6% | 48.1% | 45.0% | 46.0% | 47.9% | 45.3% | 45.0% | 46.4% | 46.5% | 45.0% | 42.1% | 48.0% |
| Employee Cost % | 18.1% | 18.8% | 19.9% | 20.2% | 18.3% | 19.1% | 18.8% | 19.0% | 18.4% | 17.8% | 17.6% | 18.2% | 17.0% | 15.4% |
| P/S | 1.75 | 1.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 21.06 | 22.50 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.40 | 1.33 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Outcome of Board Meeting
TTK Healthcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Board Meeting Intimation
Outcome of the 68th Annual General Meeting
Chairman''s Speech - 68th Annual General Meeting
Voting Results of the 68th Annual General Meeting
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular dated July 11, 2023
Board Meeting Outcome
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Business Responsibility and Sustainability Reporting (BRSR)
Annual Report for Financial Year 2025-26
Annual Report 2025-26
Annual Report for FY 2025-26 with 68th AGM Notice
Closure of Trading Window
Newspaper Publication
Record Date
Announcement under Regulation 30 of SEBI LODR.
Outcome of Board Meeting
Outcome of Board Meeting
Announcement under Regulation 30 of SEBI (LODR), 2015
Outcome of the Board Meeting 30052026
Outcome of Board Meeting
Regulation 24A - Annual Secretarial Compliance Report
TTK Healthcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Meeting of the Board of Directors ....
Newspaper Publication
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Closure of Trading Window
Newspaper Publication
Cessation of Mr. N Ramesh Rajan
Cessation of Mr. N Ramesh Rajan
Cessation of Mr. N Ramesh Rajan
Outcome of Postal Ballot 27012026
Outcome of Postal Ballot 27012026
Outcome of the Board Meeting 22012026
Outcome of the Board Meeting 22012026
Outcome of the Board Meeting 22.01.2026
TTK Healthcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2026 ,inter alia, to consider and approve Prior Board Meeting Intimation
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mukund Thattai
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mukund Thattai
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tiruvallur Lakshman
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tiruvallur Lakshman
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sarayu Thattai
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sarayu Thattai
Announcements under SEBI LODR Regulations
Closure of Trading Window
Postal Ballot Notice
Board Meeting Outcome held on December 22, 2025
Outcome of Board Meeting held on December 22, 2025
Outcome of Board meeting held on December 22, 2025
Newspaper Publication
Annual Reports
16Credit Ratings
6Concalls
1Sep 2016
30 Sept 2016